Sperimentazione clinica
NAD+ supplement shows early promise for long COVID fatigue and brain fog
Riportato dall'IA Immagine generata dall'IA Verificato
A randomized controlled trial at Massachusetts General Hospital tested high-dose nicotinamide riboside, a vitamin B3 derivative, to boost NAD+ levels in people with long COVID. Although between-group differences were limited, participants who took the supplement for at least 10 weeks reported improvements in fatigue, sleep, mood, and some executive function measures compared with their own baseline, suggesting potential benefits for some individuals despite mixed overall results.
Scientists at the University of Southern California are starting a phase 2b clinical trial to test a microscopic stem cell implant aimed at restoring vision in patients with advanced dry age-related macular degeneration. The hair-thin patch seeks to replace damaged retinal cells, building on earlier research that showed safety and vision gains in some participants. Researchers hope it could offer a way to reverse vision loss where current treatments fall short.
Riportato dall'IA
L'ospedale provinciale clinico chirurgico Comandante Faustino Pérez ha avviato una sperimentazione clinica con il farmaco cubano Jusvinza per trattare la poliartrite residua nei sopravvissuti alla chikungunya. Lo studio valuta la capacità del farmaco di ridurre il dolore persistente e l'infiammazione articolare. Coinvolge 120 pazienti e mira a offrire un'opzione di trattamento accessibile.